| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 97.47 mm | 97.47 mm | 97.47 mm | 97.47 mm | 97.47 mm | 97.47 mm |
| Cash burn (monthly) | 11.29 mm | 7.46 mm | (no burn) | (no burn) | 9.73 mm | (no burn) |
| Cash used (since last report) | 23.49 mm | 15.51 mm | n/a | n/a | 20.23 mm | n/a |
| Cash remaining | 73.99 mm | 81.96 mm | n/a | n/a | 77.24 mm | n/a |
| Runway (months of cash) | 6.6 | 11.0 | n/a | n/a | 7.9 | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 241 |
| Opened positions | 46 |
| Closed positions | 46 |
| Increased positions | 92 |
| Reduced positions | 74 |
| 13F shares | Current |
|---|---|
| Total value | 2.36 tn |
| Total shares | 73.56 mm |
| Total puts | 217.70 k |
| Total calls | 224.80 k |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| BlackRock | 9.88 mm | $381.55 bn |
| Farallon Capital Management | 5.93 mm | $228.90 bn |
| Farallon Capital Partners | 5.83 mm | $227.92 mm |
| RTW Investments | 5.50 mm | $212.24 bn |
| Vanguard | 4.22 mm | $162.89 bn |
| STT State Street | 3.33 mm | $128.58 bn |
| Biotechnology Value Fund L P | 2.97 mm | $141.45 mm |
| JNJ Johnson & Johnson | 2.45 mm | $94.54 bn |
| BVF | 1.90 mm | $73.34 bn |
| Pacer Advisors | 1.88 mm | $72.43 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 Feb 25 | Dinesh V PH D Patel | Common Stock | Sell | Dispose S | No | No | 38.18 | 5,359 | 204.61 k | 540,260 |
| 16 Jan 25 | Asif Ali | Common Stock | Sell | Dispose S | No | No | 0 | 2,601 | 0.00 | 62,821 |
| 16 Jan 25 | Asif Ali | Common Stock | Sell | Dispose S | No | No | 0 | 1,317 | 0.00 | 65,422 |
| 16 Jan 25 | Molina Arturo MD | Common Stock | Sell | Dispose S | No | No | 0 | 3,252 | 0.00 | 83,892 |
| 16 Jan 25 | Molina Arturo MD | Common Stock | Sell | Dispose S | No | No | 0 | 388 | 0.00 | 87,144 |
| 15 Jan 25 | Dinesh V PH D Patel | Common Stock | Payment of exercise | Dispose F | No | No | 0 | 12,636 | 0.00 | 545,619 |
| 2 Jan 25 | Asif Ali | Common Stock | Grant | Acquire A | No | No | 0 | 31,779 | 0.00 | 66,739 |
| 2 Jan 25 | Asif Ali | Stock Option Common Stock | Grant | Acquire A | No | No | 38.98 | 38,520 | 1.50 mm | 38,520 |
